Left Ventricular Hypertrophy and Excess Cardiovascular Mortality. Is Late Gadolinium Enhancement the Imaging Link?

Journal of the American College of Cardiology

Volumn 53, Issue 3, 2009, Pages 292-294

  Chuang, Michael L ^a   Manning, Warren J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cardiovascular magnetic resonance; gadolinium; hypertension; left ventricular hypertrophy; magnetic resonance imaging

Indexed keywords

GADOLINIUM;

ARRHYTHMOGENESIS; CARDIOVASCULAR RISK; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; EDITORIAL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; M MODE ECHOCARDIOGRAPHY; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

CAUSE OF DEATH; FEMALE; GADOLINIUM; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 58149279046     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.09.025     Document Type: Editorial

References (26)

1. Levy D., Garrison R.J., Savage D.D., Kannel W.B., and Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322 (1990) 1561-1566
2. McNamara M.T., Tscholakoff D., Revel D., et al. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology 158 (1986) 765-769
3. Wesbey G.E., Higgins C.B., McNamara M.T., et al. Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. Radiology 153 (1984) 165-169
4. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
5. Simonetti O.P., Kim R.J., Fieno D.S., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 (2001) 215-223
6. Klein C., Nekolla S.G., Bengel F.M., et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 105 (2002) 162-167
7. Wagner A., Mahrholdt H., Holly T.A., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361 (2003) 374-379
8. Kim R.J., Wu E., Rafael A., Chen E.L., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 (2000) 1445-1453
9. Beek A.M., Kühl H.P., Bondarenko O., et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 42 (2003) 895-901
10. Gerber B.L., Garot J., Bluemke D.A., Wu K.C., and Lima J.A. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 106 (2002) 1083-1089
11. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
12. Choudhury L., Mahrholdt H., Wagner A., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 2156-2164
13. Mahrholdt H., Goedecke C., Wagner A., et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109 (2004) 1250-1258
14. Assomull R.G., Prasad S.K., Lyne J., et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1977-1985
15. Smedema J.P., Snoep G., van Kroonenburgh M.P., et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45 (2005) 1683-1690
16. Vogelsberg H., Mahrholdt H., Deluigi C.C., et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 51 (2008) 1022-1030
17. Moon J.C., Sachdev B., Elkington A.G., et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 24 (2003) 2151-2155
18. Blyth K.G., Groenning B.A., Martin T.N., et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 26 (2005) 1993-1999
19. Polimeni P.I. Extracellular space and ionic distribution in rat ventricle. Am J Physiol 227 (1974) 676-683
20. Ochiai K., Ishibashi Y., Shimada T., Murakami Y., Inoue S., and Sano K. Subendocardial enhancement in gadolinium-diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging in aortic stenosis. Am J Cardiol 83 (1999) 1443-1446
21. Debl K., Djavidani B., Buchner S., et al. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart 92 (2006) 1447-1451
22. Rudolph A., Abdel-Aty H., Bohl S., et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy: relation to remodeling. J Am Coll Cardiol 53 (2009) 284-291
23. Andersen K., Hennersdorf M., Cohnen M., Blondin D., Mödder U., and Poll L.W. Myocardial delayed contrast enhancement in patients with arterial hypertension: initial results of cardiac MRI. Eur J Radiol (2008) April 22 [E-pub ahead of print].
24. Adabag A.S., Maron B.J., Appelbaum E., et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51 (2008) 1369-1374
25. Kwong R.Y., Chan A.K., Brown K.A., et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113 (2006) 2733-2743
26. Salton C.J., Gona P., Chuang M.L., et al. Gender-specific reference values for left ventricular anatomy and systolic function using modern cardiovascular magnetic resonance methods in a longitudinally followed normotensive population: the Framingham Heart Study. Circulation 114 Suppl 18 (2006) II669